VG Somani, the Drug Controller General of India said on Monday that Covishield and Covaxin are ''safe and provide a robust immune response.'' India's drugs regulator has given final emergency-use approval for two coronavirus vaccines, Serum Institute of India's Covishield, developed by Oxford University and pharma major AstraZeneca, and Bharat Biotech's Covaxin.

Covishield, Covaxin are safe and provide robust immune response, says Drug Controller General of India VG Somani

vg-somani

Vg Somani, News on Vg Somani, stories on Vg Somani, articles on Vg Somani, Vg Somani stories at Wion, Vg Somani news, Vg Somani latest news

vg somani

Covishield, Covaxin are safe and provide robust immune response, says Drug Controller General of India VG Somani